This extract was written in mid-May 2021. The analyst on the advice of RHY has based revenues on prices per test kit ($0-$50) as well as market share (40-60%) And they aren't talking millions, they are talking billions of dollars. Just makes me laugh.. Seriously, this company is putting you guys into dreamland. 40-60% market share? What an absolute joke.
The whole report for that matter is a joke. All positives, not one negative! Cmon!!!!!!!!!!!!
Inflation has increased prices from Europe, They have more inflation than US and Australia. Good luck getting the shipments of those Test kits into Australia by 30 June. LOL
